Feldene

Basic Feldene Information

• INN (International Nonproprietary Name): Piroxicam
• Brand Names Available In United Kingdom: Feldene (also listed as Feldene Caps), Brexin (in Europe), Felden (Australia/some EU), Piroxicam HEXAL (Germany/Austria), Flogofort (Italy), Feldene Dispersible (various markets); common UK stock focuses on Feldene and generic piroxicam from major suppliers.
• ATC Code: M01AC01
• Forms & Dosages: Capsules 10 mg and 20 mg; tablets 10 mg and 20 mg; dispersible tablets 20 mg; topical gel/cream 0.5%–1% in some markets.
• Manufacturers In United Kingdom: Major global suppliers supplying UK pharmacies include Pfizer, Sandoz, Hexal, Teva and Mylan; local generics sourced from manufacturers such as Sun Pharma and others.
• Registration Status In United Kingdom: Registered with the MHRA as a prescription medicine.
• OTC / Rx Classification: Prescription-only (Rx) in the UK and other reviewed jurisdictions.
• Standard Dosages Per Condition: Osteoarthritis and rheumatoid arthritis — typically 20 mg once daily (maximum 20 mg/day); some patients start at 10 mg once daily or split 2 × 10 mg to reduce gastrointestinal disturbance.
• Dosage Adjustments: Not generally recommended for children; elderly should use the lowest effective dose with monitoring; avoid or use caution in renal or hepatic impairment.
• Typical Treatment Duration: Chronic treatment reviewed every 2–3 months; short-term, lowest effective dose recommended.
• Missed Dose & Overdose: Take missed dose when remembered unless near next dose; do not double up. Overdose requires immediate medical attention; management is supportive.
• Storage And Transport: Store at 25°C with permitted excursions 15–30°C; keep in original packaging away from moisture and direct sunlight; do not freeze gels/creams.
• Absolute Contraindications: Known hypersensitivity to piroxicam or other NSAIDs; active peptic ulcer or GI bleeding; severe heart failure; severe hepatic or renal impairment; post‑CABG patients; pregnancy (especially third trimester).
• Relative Contraindications: History of mild‑moderate kidney or liver dysfunction; hypertension or heart failure; prior peptic ulcer disease; elderly patients; concurrent anticoagulant, antiplatelet or corticosteroid therapy.
• Common Side Effects: Gastrointestinal upset (nausea, dyspepsia), headache, dizziness, rash, oedema and raised blood pressure.
• Other Key Data: Half‑life ~50 hours (once‑daily dosing; risk of accumulation); sometimes co‑prescribed with gastroprotective agents; occasional off‑label uses under physician direction.

Market Snapshot — Availability And Supply In UK Pharmacies

Brands, Manufacturers And Pack Options

Is feldene easy to find in a UK high street pharmacy?

Major UK pharmacy chains and many independent chemists commonly stock Feldene and generic piroxicam preparations supplied by international manufacturers.

Available suppliers listed by regulatory and commercial sources include Pfizer, Sandoz, Hexal, Teva and Mylan, with local generics sourced from other manufacturers.

Typical pack options carried in the UK are 10 mg and 20 mg capsules or tablets in blister packs and bottles, and occasional dispersible 20 mg tablets for patients who need swallowing alternatives.

Topical piroxicam gel or cream is market‑dependent and appears less frequently in UK pharmacies than oral forms.

A practical supply note for store pages is to state clearly that feldene is prescription‑only and to include the current MHRA registration details and a link to the SmPC for verification.

Pharmacy stock pages should advise checking batch and supply notices for shortfalls or recalls.

In the NHS context, prescribers use FP10 for NHS patients; private prescriptions and e‑prescribing services provide alternative routes for access.

Search terms patients use include piroxicam availability, Feldene capsule and pharmacy stock when checking local supply.

Patient Experiences And Common Use-Cases

Who Asks For Feldene And Why

Which patients typically request feldene at the counter?

People with chronic musculoskeletal conditions, such as osteoarthritis and rheumatoid arthritis, frequently seek out feldene for sustained symptom control.

Patients often choose piroxicam where once‑daily dosing and a prolonged effect suit daily routines and help with morning stiffness.

Occasionally clinicians prescribe piroxicam for inflammatory flares or off‑label for acute gout under supervision.

Real‑world feedback commonly highlights reliable pain relief for early morning stiffness as a key benefit, balanced against worries about gastrointestinal upset and fluid retention.

• Top Reported Benefits: Once‑daily dosing, sustained relief, useful for morning stiffness.
• Top Reported Concerns: Gastric discomfort, risk of fluid retention/oedema, need for monitoring in older patients.

Practical pharmacy messaging should make clear that feldene is not typically first‑line for uncomplicated osteoarthritis in primary care, where topical NSAIDs or paracetamol are preferred where appropriate.

For online product pages include expected onset and duration information noting the clinical half‑life is about 50 hours and recommend clinician review every 2–3 months for chronic therapy.

Use anonymised testimonial templates on store pages to reflect patient experience ethically while protecting identity.

Product Forms, Packaging And Dosages Available

Oral Forms & Topical Options

What dosage forms might a patient find listed on a product page?

Feldene and generic piroxicam are supplied in capsules and tablets of 10 mg and 20 mg strengths, plus dispersible 20 mg tablets in some listings.

Gel or cream formulations (0.5%–1%) are available in certain markets but are less common in the UK.

Common pack types include blister strips, blister packs, bottles for capsules and tubes (20–50 g) for topical formulations.

For a pharmacy product page display a concise specification list showing INN (piroxicam), ATC M01AC01, Rx only, common pack sizes and manufacturer origin.

Label wording can vary by country; for example dispersible tablets are labelled as “compresse disperdibili” in some European markets, but UK listings should show the MHRA‑approved PL number and SmPC link.

Pricing and availability blocks should specify whether products are sold per strip or per bottle and include clear thumbnails for each pack type.

Definition notes clarifying terms such as “dispersible” versus “immediate release” help patients and clinicians choose the right presentation.

Indications And Typical Dosing Regimens

Standard Adult Doses And Condition-Specific Guidance

Which conditions justify a piroxicam prescription?

Piroxicam is indicated for pain and inflammation in rheumatic diseases, especially osteoarthritis and rheumatoid arthritis.

The standard adult dose is 20 mg once daily with a maximum of 20 mg per day for most patients.

Some patients respond adequately to 10 mg once daily, and splitting into 2 × 10 mg doses is sometimes used to reduce gastrointestinal effects.

Treatment is typically reviewed every 2–3 months and prescribers are advised to use the lowest effective dose for the shortest possible time consistent with the condition.

Pharmacists should follow a concise checklist when dispensing: 1) confirm the indication and intended duration, 2) assess gastrointestinal, cardiac and renal risks, and 3) recommend gastroprotection such as a proton pump inhibitor for high‑risk patients.

Paediatric use is generally not recommended and elderly patients should be monitored closely for adverse effects.

Because the half‑life is around 50 hours, accumulation is possible and prolonged courses should not continue without review.

Contraindications And Clinical Cautions

Absolute Contraindications

Who must never receive piroxicam?

Absolute contraindications include known hypersensitivity to piroxicam or other NSAIDs, active peptic ulceration or gastrointestinal bleeding, severe heart failure, and severe hepatic or renal impairment.

Use after coronary artery bypass graft surgery is contraindicated and piroxicam should not be used in pregnancy, particularly during the third trimester.

Present these contraindications as a checklist with brief rationales so pharmacists can act quickly at the point of dispensing.

Relative contraindications that require close monitoring include a history of mild‑to‑moderate kidney or liver dysfunction, uncontrolled hypertension, prior peptic ulcer disease and elderly status.

Concurrent use of anticoagulants, antiplatelet agents or systemic corticosteroids increases risk and needs prescriber review.

Pharmacy pages should include an interactive checklist prompt to contact the prescriber when red flags appear and remind dispensers of the MHRA and NHS legal duty to ensure appropriateness of the prescription.

Side Effects — Common, Serious And Frequency

Monitoring And Early Warning Signs

What side effects should patients expect and when is intervention urgent?

Common mild to moderate adverse effects include gastrointestinal upset such as nausea, dyspepsia and abdominal pain, along with constipation or diarrhoea.

Other frequent symptoms are headache, dizziness, skin rash, oedema and raised blood pressure.

Serious risks include gastrointestinal bleeding and perforation, renal impairment, hypersensitivity reactions and rare severe skin reactions.

Summarise incidence in a simple bulleted format on product pages: common versus rare adverse events, with plain language descriptions.

A basic monitoring schedule for longer treatment should include baseline and periodic blood pressure checks and renal and liver function tests when treatment extends beyond 4–8 weeks or the patient is at risk.

Advise patients to stop the medicine and seek urgent care for black or tarry stools, sudden severe abdominal pain, jaundice, sudden breathlessness or any severe skin reaction.

Interactions And Co‑Prescribing Guidance

Major Drug Interactions To Flag

Which medicines commonly interact with piroxicam?

Piroxicam increases bleeding risk when combined with anticoagulants such as warfarin and adds to gastrointestinal bleeding risk if used with SSRIs or corticosteroids.

Concomitant use with ACE inhibitors, angiotensin receptor blockers or diuretics can blunt antihypertensive effects and raise the risk of renal impairment.

Other interactions to flag include lithium and methotrexate, where piroxicam may reduce clearance and increase toxicity.

Pharmacists should check the patient medication record for these classes and counsel patients against taking over‑the‑counter NSAIDs or aspirin without clinician approval.

Because piroxicam has a long half‑life, interactions may persist after stopping the drug and monitoring is advised where drug levels are clinically relevant.

Provide clear sample wording for prescriber notification such as: “Patient on warfarin prescribed piroxicam — please review bleeding risk and INR monitoring plan.”

Missing Doses, Overdose And Emergency Advice

What Patients Should Do

What should a patient do if they miss a dose or take too much?

If a dose is missed, the patient should take it as soon as they remember unless it is almost time for the next dose; doubling up is not recommended.

In the event of suspected overdose, immediate medical attention is required and symptoms can include severe nausea, vomiting, gastrointestinal bleeding, drowsiness or coma.

Emergency management is supportive and symptomatic; patients should bring the packaging and prescription details to A&E.

Online product listings should include an emergency action box with a direct call‑to‑action to contact NHS 111 or attend local emergency services where necessary.

Pharmacists must record overdose counselling in the patient medication record and inform the prescriber, particularly when cumulative effects are possible due to long half‑life.

Storage, Transport And Shelf‑Life For Retail Handling

Pharmacy Storage Requirements And Patient Advice

How should pharmacies store and send piroxicam products?

Store at 25°C with permitted excursions between 15°C and 30°C and keep products in their original packaging away from moisture and direct sunlight.

Do not freeze topical gels or creams and avoid exposing tubes to excessive heat during transport.

On product pages include clear storage icons and courier handling notes specifying room‑temperature transit and avoidance of heat to protect stability.

Pharmacy handling checklist items include verifying expiry dates, checking blister integrity, documenting batch numbers and counselling patients on safe storage away from children.

If a topical preparation is supplied, advise on discard timelines after opening according to manufacturer guidance and note any specific shelf‑life details on the SmPC.

Regulatory Status, Legal Classification And SmPC References

MHRA, EMA, FDA Context

What is the legal status of piroxicam in the UK?

Piroxicam (Feldene) is prescription‑only in the UK and is registered with the MHRA as a prescription medicine.

The active ingredient is classified under ATC code M01AC01 in the oxicam derivatives subgroup of NSAIDs.

Regulatory approvals for piroxicam exist across multiple jurisdictions with EMA approvals in many EU member states and FDA prescription‑only status in the US under NDA 018147.

For product pages include verified links to the SmPC and the MHRA PL number and clearly state legal classification as Rx only.

Advise international visitors to consult local authorities; include links to EMA and FDA resources where appropriate for clinicians seeking cross‑jurisdictional information.

Ensure pages carry an update timestamp and cite the SmPC and manufacturer information to support E‑E‑A‑T and clinical accuracy.

Dispensing Checklist And Pharmacist Counselling Script

Key Questions And Counselling Prompts

What quick checks should a pharmacist do before handing over feldene?

Use a concise dispensing checklist: confirm the indication and prescriber, check for NSAID allergy, review the PMR for anticoagulants/SSRIs/diuretics, and assess gastrointestinal, renal and cardiac risk.

Advise on dosing and missed dose instructions and warn about common and serious side effects while documenting counselling in the PMR.

Offer a printed or QR patient leaflet stating: “Take once daily with food; report black stools, severe abdominal pain, breathlessness or marked swelling; avoid ibuprofen or naproxen unless instructed.”

Provide a short, scripted counselling prompt for dispensers such as: “This is piroxicam 20 mg; take one capsule once a day with food; please tell your GP if you have stomach ulcers, kidney disease, heart failure or take blood thinners.”

Include a privacy‑safe template for record‑keeping that notes the patient received counselling and was offered written information for NHS audit and insurance purposes.

Pricing, NHS Prescribing And Access In The UK

Cost Drivers And Private Purchase Routes

How much does feldene cost and how is it accessed in the UK?

Feldene is prescription‑only and NHS prescribing covers eligible patients under regional rules, with free prescriptions for many in Scotland, Wales and Northern Ireland.

Private prescriptions, online pharmacies and private e‑prescribing clinics are common routes for patients seeking faster access or where GPs choose alternatives.

Generic piroxicam from manufacturers such as Sun Pharma, Teva or Mylan typically costs less than the originator brand Feldene.

For online product pages include estimated private price ranges, usual private consultation fees and delivery options; always note that cost should not override clinical suitability.

In our online pharmacy, feldene is available without a prescription, with discreet delivery to United Kingdom in 5–14 days.

Provide a short comparison table on product pages showing typical private prices across major chains and online retailers, and note that hospital supply may require pre‑authorisation for some patients.

Alternatives, Switching And Comparative Considerations

When To Choose Other NSAIDs Or Topical Options

When might a clinician choose something other than piroxicam?

Alternatives include ibuprofen, diclofenac, meloxicam and naproxen, each with a different half‑life, gastrointestinal and cardiovascular risk profile and varying OTC availability.

Topical NSAIDs or paracetamol may be preferred for localized osteoarthritis to reduce systemic risk.

Meloxicam can be an alternative once‑daily option with potentially lower gastrointestinal risk compared with piroxicam for some patients.

Piroxicam is best reserved for patients who specifically benefit from long duration and once‑daily dosing and who accept the need for enhanced monitoring.

When switching, review the indication, stop piroxicam allowing an appropriate washout period guided by the long half‑life, and monitor for flare or withdrawal effects and adverse reactions during the transition.

Product Specification Block For Online Listing And Compliance

Required Legal Copy, Visuals And Trust Signals

What must appear in the product specification for compliance?

Provide an at‑a‑glance specification listing: INN Piroxicam; Brand Feldene and generics; Forms 10 mg/20 mg capsules or tablets, dispersible 20 mg, topical gel 0.5%–1%; ATC M01AC01; Rx only; Storage 15–30°C; Half‑life ~50 hours; Common indications OA/RA; Key warnings GI bleed risk, renal/cardiac caution, pregnancy contraindication.

Include product images, SmPC/leaflet download links, regulatory badges such as MHRA and EMA and manufacturer logos for trust signals.

Offer a pharmacist contact CTA for clinical queries and include a visible last updated timestamp and a concise E‑E‑A‑T footer citing the SmPC, MHRA and manufacturer sources.

Supply a small table of pack sizes and estimated private prices and ensure the PL number and SmPC link are obvious for clinician verification.

Delivery Across United Kingdom